Application
SFRS8 Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the SFRS8 antibody detected the SFRS8 protein (arrow).| Product Name | SFRS8 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SFSWAP; SFRS8; SWAP; Splicing factor, suppressor of white-apricot homolog; Splicing factor, arginine/serine-rich 8; Suppressor of white apricot protein homolog |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | SFRS8 SWAP |
|---|---|
| Alternative Names | SFSWAP SFRS8 SWAP Splicing factor suppressor of white-apricot homolog Splicing factor arginine/serine-rich 8 Suppressor of white apricot protein homolog |
| Molecular Weight(MW) | 104822 Da |
| Function | Plays a role as an alternative splicing regulator. Regulate its own expression at the level of RNA processing. Also regulates the splicing of fibronectin and CD45 genes. May act, at least in part, by interaction with other R/S-containing splicing factors. Represses the splicing of MAPT/Tau exon 10 |
| Tissue Specificity | This SFRS8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human SFRS8. |
| Cellular Localization | Nucleus (Potential). |
| Entrez Gene | 6433 |
|---|---|
| Nucleotide Accession | NP_004583.2 |
Application
SFRS8 Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the SFRS8 antibody detected the SFRS8 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
